Clinical biomarkers for detection of ovarian cancer


Journal of Molecular Cancer is an open access, peer reviewed, scholarly journal that aims to enhance our understanding on the genesis, diagnosis, consequences of cancer molecules by critiquing the literature on Molecular Cancer, Cell and Tumor Biology, Angiogenesis, Cancer Antigens, Cellular Signaling and Molecular Biology, Genetic And Molecular Profiling of Cancer, DNA Damage and Repair, Cell Cycle, Metastasis.

Between all of the gynecological cancers, ovarian cancer (OvCa) shows high clinical challenge because it is difficult to be detected in early stage and it has the highest mortality proportional to the other gynecologic malignancies. Despite medical advances and the development of diagnostic tools such as biomarkers and detection techniques, OvCa remains a fatal cancer with high progression. There are different types of OvCa based on histological classification; Epithelial Ovarian Cancer (EOC) is the most common, whereas, stromal and germ cell tumors are of lower abundance. EOC is identified in over 80% of women at late-stage with complications include the spread of tumor implants throughout the peritoneal cavity. Early diagnosis of OvCa is helpful in the treatment and promotion of survival rate. Such diagnostic medical methods and biomarkers include vaginal and pelvic examination, diagnostic imaging, serum CA125, and screening tests or a combination used in medical centers, however, it is necessary to find new biomarkers with long-term stability and high specificity and sensitivity to detect OvCa in early stages of disease. This review presents novel and robust biomarkers and methods for detecting OvCa.

The journal invites different types of science communications including original research articles, systematic reviews, short note communications, case reports, and editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

A standard editorial tracking system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded at Author(s) can submit their manuscript(s) online via Online Manuscript Submission System Or as an E-mail attachment to the editorial office at

Julia Gillard
Managing Editor
Journal of Molecular Cancer
Whats App: +1-947-33-4405